Atrás
Precio Starpharma Holdings Ltd (SPHRY)
Gráfico del Precio de Acciones SPHRY
SPHRY Ganando
Starpharma Holdings Ltd
$2.3
-11.53%
$-0.3
Al cierre: Jan 16, 16:00:00 GMT-5
$2.3
0%
$0
Mercado Posterior: Jan 16, 20:00:00 GMT-5
Estadísticas clave
Cierre Anterior
$2.6
Precio de apertura
$2.3
Rango del día
$2.3 - $2.3
Rango de 52 semanas
$0.47 - $2.86
Volumen
1.1K
Volumen promedio
1.0K
EPS (TTM)
-0.16
Rendimiento de dividendos
--
Cap. de mercado
$96.1M
¿Qué es SPHRY?
Starpharma Holdings Ltd. engages in the research, development, and commercialization of dendrimer products for pharmaceutical and healthcare applications. The firm's principal activities are focused on the research, development and commercialization of dendrimer technology for pharmaceutical and healthcare applications. The firm's portfolio of dendrimer-based products includes three clinical-stage dendrimer enhanced product (DEP) assets, preclinical radiopharmaceutical assets, research collaborations, and three commercially marketed over the counter (OTC) products. Its clinical-stage assets, DEP SN38, DEP cabazitaxel, and DEP docetaxel, are dendrimer-based chemotherapeutic drugs. Additionally, the Company has a preclinical pipeline of DEP radiopharmaceuticals in development. The company also manufactures and sells SPL7013 (astodrimer sodium) proprietary products: VivaGel BV, Viraleze nasal spray, and VivaGel condom. The firm has applied its DEP technology to the innovative area of antibody-drug conjugates.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved